Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: A Pilot Study of Non-Hodgkin's Lymphoma: Chemotherapy and Blood Levels of Organochlorines
A completed pilot trial in non-Hodgkin lymphoma evaluates chemotherapy and blood levels of organochlorines.
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma
Clinical trial update reporting on analysis of molecular markers related to drug resistance in tumor biopsies from patients with previously …
-
CLINICAL_TRIALS trial_result · 2008-02-28Clinical Trial Update: Pegfilgrastim PBPC Mobilization Study [Phase 2]
Completed Phase 2 clinical trial sponsored by Amgen evaluating pegfilgrastim for peripheral blood progenitor cell mobilization in patients w…
-
CLINICAL_TRIALS trial_result · 2008-01-28Clinical Trial Update: Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 trial of bortezomib combined with rituximab for relapsed or refractory B-cell non-Hodgkin's lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2008-01-10Clinical Trial Update: Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating Rituximab with high-dose chemotherapy in patients with poor-prognosis Non-Hodgkin's lymphoma was termina…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-12-28Clinical Trial Update: Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade) [Phase 2]
Phase 2 trial evaluating a monoclonal antibody therapy for low-grade non-Hodgkin's lymphoma sponsored by Amgen has completed.
-
CLINICAL_TRIALS research · 2007-12-28Clinical Trial Update: BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma [Phase 1]
The update indicates that the Phase 1 trial of the BL22 immunotoxin for relapsed or refractory acute lymphoblastic leukemia or non-Hodgkin l…
-
CLINICAL_TRIALS trial_result · 2007-11-20Clinical Trial Update: Safety and Efficacy Study of Salvage Chemotherapy (R-ESHAP) to Treat Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 safety and efficacy study of salvage chemotherapy R-ESHAP for relapsed or refractory aggressive Non-Hodgkin lymphoma has been term…
-
CLINICAL_TRIALS trial_result · 2007-11-16Clinical Trial Update: Pegylated Liposomal Doxorubicin Containing Chemotherapy in the Treatment of Older Non-Hodgkin's Lymphoma Patients [Phase 2]
Phase 2 trial evaluating pegylated liposomal doxorubicin in older adults with Non-Hodgkin lymphoma has been terminated.
-
FDA label_change · 2007-11-02FDA Approved: ZEVALIN — Supplemental Application (Acrotech Biopharma Inc)
FDA granted approval of a supplemental application for Zevalin (ibrutinomab tiuxetan) submitted by Acrotech Biopharma, resulting in updated …
-
CLINICAL_TRIALS trial_result · 2007-11-01Clinical Trial Update: Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients [Phase 1, Phase 2]
Phase 1/Phase 2 trials evaluated the safety of combining interferon gamma-1b with rituximab in patients with non-Hodgkin's lymphoma; the stu…
-
CLINICAL_TRIALS trial_result · 2007-10-15Clinical Trial Update: Study of TPI 287 Administered Every 21 Days in Patients With Advanced Malignancies [Phase 1]
This is a completed Phase 1 study evaluating TPI-287 administered every 21 days in patients with advanced malignancies, including Hodgkin ly…
-
FDA approval · 2007-10-15FDA Approved: FLUDARABINE — Original Application (Fresenius Kabi USA, LLC)
FDA approved the original application for Fludarabine phosphate (generic fludarabine) from Fresenius Kabi USA, LLC. The approval covers use …
-
CLINICAL_TRIALS trial_result · 2007-08-15Clinical Trial Update: Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma [Phase 2]
Phase 2 study evaluating ABT-510 for refractory lymphoma has completed. The provided snippet references the trial status but does not includ…
-
CLINICAL_TRIALS trial_result · 2007-08-14Clinical Trial Update: Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease [Phase 1]
Phase 1 safety study of CAT-8015 (Immunoxin) in patients with advanced non-Hodgkin lymphoma and leukemia.
-
CLINICAL_TRIALS trial_result · 2007-07-30Clinical Trial Update: Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders. [Phase 3]
Phase 3 trial evaluating adjuvant intravenous iron therapy during erythropoietin treatment for anemia in patients with lymphoproliferative d…
-
CLINICAL_TRIALS trial_result · 2007-07-25Clinical Trial Update: Safety/Tolerance Study of PPI-2458 in Subjects With Non-Hodgkin's Lymphoma and Solid Tumors [Phase 1]
Termination of a Phase 1 safety/tolerance study of PPI-2458 in subjects with Non-Hodgkin lymphoma and solid tumors.
-
CLINICAL_TRIALS trial_result · 2007-06-25Clinical Trial Update: Cisplatin With Gemcitabine With Dexamethasone in Patients With Aggressive Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating cisplatin plus gemcitabine with dexamethasone in patients with aggressive Non-Hodgkin lymphoma has completed. The s…
-
CLINICAL_TRIALS trial_result · 2007-05-15Clinical Trial Update: Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma [Phase 2]
This update notes that a Phase 2 clinical trial of motexafin gadolinium for non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS research · 2007-05-07Clinical Trial Update: Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia [Phase 1, Phase 2]
This clinical trial update covers a Phase 1/2 study of AQ4N in patients with Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small …
-
CLINICAL_TRIALS trial_result · 2007-05-04Clinical Trial Update: Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia [Phase 3]
Phase 3 trial update evaluating safety and efficacy of PN-152,243 and PN-196,444 in preventing thrombocytopenia in patients with Non-Hodgkin…
-
FDA approval · 2007-04-30FDA Approved: METHOTREXATE — Original Application (Accord Healthcare, Inc.)
The FDA approved Accord Healthcare's original application for Methotrexate (generic).
-
CLINICAL_TRIALS trial_result · 2007-04-23Clinical Trial Update: Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood [Phase 2]
This is a Phase 2 trial update evaluating low-intensity conditioning and immunotherapy for high-risk blood cancers; the study has been termi…
-
CLINICAL_TRIALS trial_result · 2007-04-12Clinical Trial Update: Infusion of Specially Treated Umbilical Cord Stem Cells After Chemoradiation Treatment for Blood Cancers [Phase 1, Phase 2]
Completed Phase 1/2 clinical trial assessing infusion of ex vivo treated umbilical cord blood stem cells following chemoradiation in patient…
-
CLINICAL_TRIALS research · 2007-03-26Clinical Trial Update: Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation [Phase 3]
A Phase 3 clinical trial update from Technische Universität Dresden evaluates Helicobacter eradication followed by radiation therapy for lym…